Aims and Scope of ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less
Key Metrics
CiteScore 

6.6
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
SJR 

Q2Biochemistry

SNIP 

0.93
Recommended pre-submission checks
Powered by 

Topics Covered on ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | AMER CHEMICAL SOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ACS Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ACS Medicinal Chemistry Letters
Solid-Phase Synthesis and Biological Evaluation of Des-hydroxy Pseudouridimycin Analogs
- 11 Mar 2026
- ACS Medicinal Chemistry Letters
Ugi-Tetrazole-Derived α-Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV-2 3CLpro
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Potent Neuronal Nicotinamide Adenine Dinucleotide-Boosting Tetrahydroquinoxalines: Structure–Activity Relationships and Early Drug Metabolism and Pharmacokinetics Evaluation
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Novel Compounds for Treating Huntington’s Disease
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Novel Compounds as MALT1 Inhibitors for Treating Cancer
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6
- 3 Mar 2026
- ACS Medicinal Chemistry Letters
Solid-Phase Synthesis and Biological Evaluation of Des-hydroxy Pseudouridimycin Analogs
- 11 Mar 2026
- ACS Medicinal Chemistry Letters
Ugi-Tetrazole-Derived α-Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV-2 3CLpro
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Potent Neuronal Nicotinamide Adenine Dinucleotide-Boosting Tetrahydroquinoxalines: Structure–Activity Relationships and Early Drug Metabolism and Pharmacokinetics Evaluation
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Novel Compounds for Treating Huntington’s Disease
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Novel Compounds as MALT1 Inhibitors for Treating Cancer
- 4 Mar 2026
- ACS Medicinal Chemistry Letters
Discovery of Pyridopyrazine Inverse Agonists Targeting G Protein-Coupled Receptor 6
- 3 Mar 2026
- ACS Medicinal Chemistry Letters
FAQs on ACS Medicinal Chemistry Letters
How long has ACS Medicinal Chemistry Letters been actively publishing? 
What is the publishing frequency of ACS Medicinal Chemistry Letters? 
How many articles did ACS Medicinal Chemistry Letters publish last year? 
What is the eISSN & pISSN for ACS Medicinal Chemistry Letters? 
What is Citescore for ACS Medicinal Chemistry Letters? 
What is SNIP score for ACS Medicinal Chemistry Letters? 
What is the SJR for ACS Medicinal Chemistry Letters? 
Who is the publisher of ACS Medicinal Chemistry Letters? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary